Quantum-Si to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

BRANFORD, Conn.--(BUSINESS WIRE)-- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company^TM, today announced that it will be participating in the 26^th Annual H.C. Wainwright Global Investment Conference taking place in New York City September 9-11, 2024.

Jeff Hawkins, Quantum-Si's Chief Executive Officer, will participate in a fireside chat on Tuesday, September 10^th, at 4:00 PM ET.

A live and archived webcast of the event will be available in the “Investors” section of the Quantum-Si website under Events & Presentations.

About Quantum-Si Incorporated
Quantum-Si, The Protein Sequencing Company™, is focused on revolutionizing the growing field of proteomics. The Company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable next-generation single-molecule protein sequencing and digitize proteomic research in order to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing. Learn more at quantum-si.com or follow us on LinkedIn or X.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240826297214/en/

Investor Contact

Doug Farrell, VP, Investor Relations

ir@quantum-si.com

Media Contact

Katherine Atkinson, SVP of Commercial Marketing

media@quantum-si.com

Source: Quantum-Si Incorporated